US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader

First Page		Document Content
GlaxoSmithKline Glucocorticoids Organofluorides Combination drugs Fluticasone/salmeterol Budesonide/formoterol Formoterol Chronic obstructive pulmonary disease Salmeterol Pulmonology Respiratory therapy Medicine		US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1.004,46 KB Share Document on Facebook

	Chronic Obstructive Pulmonary Disease: Open Access DocID: 1rMT2 - View Document
	DOC Document DocID: 1rs8N - View Document
	The Dangers to Health from Health Effects of Wood Smoke Exposures W DocID: 1rkGG - View Document
	Statement of Israel Rappaport Before the House Committee on Interstate and Foreign Commerce on Bills Relating to Cigarette Labeling and Advertising DocID: 1rc0I - View Document
	LIES, DAMNED LIES, & 400,000 SMOKING-RELATED DEATHS by Robert A. Levy and Rosalind B. Marimont T RUTH WAS AN EARLY VICTIM in the battle against tobacco. The big lie, repeated ad nauseam in anti-tobacco circles, is that s DocID: 1rbkp - View Document